Issue 10/2019
Content (8 Articles)
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Sabine E. Grimm, Debra Fayter, Bram L. T. Ramaekers, Svenja Petersohn, Rob Riemsma, Nigel Armstrong, Xavier Pouwels, Willem Witlox, Caro Noake, Gillian Worthy, Jos Kleijnen, Manuela A. Joore
Tisagenlecleucel for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia in People Aged up to 25 Years: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Matthew Walton, Sahar Sharif, Mark Simmonds, Lindsay Claxton, Robert Hodgson
Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review
Xiao Zang, Emanuel Krebs, Linwei Wang, Brandon D. L. Marshall, Reuben Granich, Bruce R. Schackman, Julio S. G. Montaner, Bohdan Nosyk, Czarina N. Behrends, Carlos Del Rio, Julia Dombrowski, Daniel J. Feaster, Kelly Gebo, Matthew Golden, Reuben Granich, Thomas Kerr, Gregory Kirk, Brandon D. L. Marshall, Shruti H. Mehta, Lisa Metsch, Julio S. G. Montaner, Bohdan Nosyk, Bruce R. Schackman, Steven Shoptaw, William Small, Steffanie Strathdee
Cost Effectiveness of Advanced Pharmacy Services Provided in the Community and Primary Care Settings: A Systematic Review
Dalia M. Dawoud, Alexander Haines, David Wonderling, Joanna Ashe, Jennifer Hill, Mihir Varia, Philip Dyer, Julian Bion
Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations
Jesse Elliott, Sasha van Katwyk, Bláthnaid McCoy, Tammy Clifford, Beth K. Potter, Becky Skidmore, George A. Wells, Doug Coyle
Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand
Khachen Kongpakwattana, Zanfina Ademi, Thanaputt Chaiyasothi, Surakit Nathisuwan, Ella Zomer, Danny Liew, Nathorn Chaiyakunapruk
Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013
Elizabeth D. Brouwer, Anirban Basu, Kai Yeung
Comment on: ‘The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study’
Livio Garattini, Anna Padula